Abstract
Recent animal models have shown that angiotensin II converting enzyme inhibitors (ACEI) prevent electrical remodeling in atrial fibrillation. The molecular mechanism of ACEI prevention of atrial remodeling still remain not well known.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
